Details of Disease

General Information of Disease (ID: DISGAODP)

Disease Name Eosinophilic asthma
Disease Class CB02: Pulmonary eosinophilia
Disease Hierarchy
DIS01GPL: Grass pollen hypersensitivity
DISGAODP: Eosinophilic asthma
ICD Code
ICD-11
ICD-11: CB02.0
ICD-9
ICD-9: 493
Expand ICD-11
'CB02.0
Expand ICD-9
493

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)
This Disease is Treated as An Indication in 1 Approved Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
Reslizumab DM0AUCH Approved Monoclonal antibody [1]
------------------------------------------------------------------------------------
This Disease is Treated as An Indication in 1 Clinical Trial Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
Dexpramipexole DM6KXAU Phase 3 Small molecule [2]
------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8091).
2 ClinicalTrials.gov (NCT05763121) A Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Assess the Efficacy, Safety, and Tolerability of Dexpramipexole Administered Orally for 52 Weeks in Participants With Severe Eosinophilic Asthma. U.S.National Institutes of Health.